SARS Vaccine
Long-lived memory T cell responses to SARS antigen in recovered SARS patients are described
Published in Medical Letter on the CDC and FDA, October 8th, 2006
According to that report from researchers in China and the United States, "The role of cell-mediated immunity in human SARS-CoV infection is still not well understood. In this study, we found that memory T-cell responses against the spike (S) protein were persistent for more than one year after SARS-CoV infection by detecting the production of IFN-gamma using ELISA and ELISpot assays."
Flow cytometric analysis showed that both CD4+ and CD8+ T cells were involved in cellular...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Antibacterial Agents
Intrapartum antibiotics prevent Escherichia coli infection only for term infants - Cancer Therapy
Antitumor responses are enhanced by B-cell depletion via decrease in IL-10 production - Cardiovascular Disease
Inhibition of rapamycin target modulates adhesion molecule expression - HIV/AIDS Epidemiology
HIV/AIDS epidemiology of adolescents and young adults in U.S. is reported - Rotavirus Vaccine
Restricting rotavirus vaccination schedule did not decrease risk of intussusception - Alcohol Use
Adolescent alcohol abuse and dependence are affected by parental factors - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
